Noscendo GmbH, a Duisburg (Germany) based molecular diagnostics company, changes the way infection causative microbes are identified. Introducing a paradigm shift using proprietary algorithms and software harnessing next generation sequencing of cell free nucleic acids isolated from patient samples Noscendo brings the concept of liquid biopsy into the field of infectious diseases. Noscendo’ s software solution is capable of differentiating infection from non-infectious signals and thereby aiding intensive care clinicians in their daily task to find the right decisions, enabling a targeted and successful treatment in an actionable timeframe.
Location: Germany, North Rhine-Westphalia, Duisburg
Employees: 11-50
Phone: +49 2066 5068770
Founded date: 2016
Investors 4
| Date | Name | Website |
| 15.10.2020 | Earlybird ... | earlybird.... |
| - | SquareOne | squareone.... |
| - | Paua Ventu... | pauaventur... |
| - | High-Tech ... | htgf.de |
Mentions in press and media 3
| Date | Title | Description | Source |
| 23.04.2020 | Noscendo Raises Series A Funding | Noscendo GmbH, a Duisburg, Germany-based diagnostics company dedicated to the identification and ass... | finsmes.co... |
| 23.12.2019 | MIT Technology Review presents the Innovators Under 35 Europ... | Since 1999, MIT Technology Review recognizes the young innovators and most talented entrepreneurs fr... | startupsre... |
| - | Noscendo closes Financing Round for CE Certification and Mar... | The diagnostic procedures developed by Noscendo help intensive care clinicians to identify the relev... | htgf.de/en... |